Results 21 to 30 of about 1,069 (160)

L-ASPARAGINASE INDUCED HYPOFIBRINOGENEMIA: A CASE REPORT [PDF]

open access: yes, 2017
Anticancer therapy is always known to cause various side effects. L-asparaginase used in the treatment of adult T-cell lymphoblastic leukemia is anovel class of drug, an enzyme produced from plants as well as microorganisms except human.
Balaji Ommurugan   +2 more
core   +3 more sources

Sintilimab, a PD-1 Inhibitor, Completely Reversed Rarely Refractory Hypofibrinogenemia in a Gastric Cancer Patient: A Case Report and Review of the Literature

open access: yesFrontiers in Oncology, 2020
While cancer is often related to hyperfibrinogenemia, it is rarely related to hypofibrinogenemia. Specifically, gastric cancer concomitant with unprovoked hypofibrinogenemia and the corresponding treatment approach have been rarely reported. We presented
Shuzhen Ma   +10 more
doaj   +1 more source

Eravacycline Associated Hypofibrinogenemia: A Case Series of Transplant Patients With Mycobacterium Abscessus Infections and Review of Literature [PDF]

open access: yes, 2022
Eravacycline is a synthetic fluorocycline within the tetracycline class of antimicrobials. Eravacycline is active in vitro against several clinically important Gram-positive and Gram-negative bacteria.
Marx A.   +9 more
core   +1 more source

Pediatric Fibrinogen PART I—Pitfalls in Fibrinogen Evaluation and Use of Fibrinogen Replacement Products in Children

open access: yesFrontiers in Pediatrics, 2021
Fibrinogen is a key coagulation protein, playing a critical role in hemostasis. It is the first factor to decrease to critical levels during bleeding. Hypofibrinogenemia is an important risk factor for bleeding in clinical settings, including pediatric ...
Elise J. Huisman   +3 more
doaj   +1 more source

Case Report: Life-Threatening Post-operative Hemorrhage in Klippel–Trenaunay Syndrome Associated With Hypofibrinogenemia

open access: yesFrontiers in Medicine, 2021
Klippel–Trenaunay Syndrome (KTS) is a rare congenital disorder, characterized by venous and lymphatic malformations of the skin, soft tissue, and bone, causing limb hypertrophy.
Hongna Yang   +4 more
doaj   +1 more source

Physiological correction of hereditary mild hypofibrinogenemia during pregnancy

open access: yes, 2023
Introduction: Hereditary hypofibrinogenemia is a rare fibrinogen disorder characterised by decreased levels of fibrinogen. Pregnant women with hypofibrinogenemia are at risk of adverse obstetrical outcomes, depending on the fibrinogen level.
Marguerite Neerman‐Arbez   +9 more
core   +1 more source

A rare heterozygous variant in FGB (Fibrinogen Merivale) causing hypofibrinogenemia in a Swedish family

open access: yes, 2020
Fibrinogen is essential for normal hemostasis. Congenital fibrinogen disorders (afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia and hypodysfibrinogenemia), caused by pathogenic variants in the genes FGA, FGB and FGG, have the potential of causing ...
Rossing, Maria   +9 more
core   +2 more sources

Incidence, characteristics and risk factors of hypofibrinogenemia associated with tigecycline: A multicenter retrospective study in China

open access: yesFrontiers in Pharmacology, 2022
Background: Tigecycline was recently found to cause coagulation disorders, especially hypofibrinogenemia, which may interfere with the administration of antimicrobial therapy.
Bing Leng   +15 more
doaj   +1 more source

Gastrointestinal bleeding after endoscopic mucosal resection in a case of Peutz–Jeghers syndrome with hypofibrinogenemia: A case report

open access: yesFrontiers in Pediatrics, 2022
BackgroudPeutz–Jegers syndrome (PJS) is an autosomal dominant hereditary disorder characterized by hamartomatous polyposis of the entire gastrointestinal tract.
Toshihiko Kakiuchi   +5 more
doaj   +1 more source

Risk Factors for Tigecycline-Associated Hypofibrinogenemia

open access: yesTherapeutics and Clinical Risk Management, 2021
Jia Liu,1 Yingying Yan,2 Fan Zhang1 1Department of Geriatrics, Peking University Third Hospital, Beijing, People’s Republic of China; 2Department of Pharmacy, Peking University Third Hospital, Beijing, People’s Republic of ChinaCorrespondence:
Liu J, Yan Y, Zhang F
doaj  

Home - About - Disclaimer - Privacy